IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells

Clinical and Experimental Allergy

Volumn 38, Issue 6, 2008, Pages 936-946

  Chibana, K ^a,c   Trudeau, J B ^a   Mustovitch, A T ^a   Hu, H ^a   Zhao, J ^a   Balzar, S ^a   Chu, H W ^b   Wenzel, S E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Air liquid interface; Asthma; Epithelial cells; IL 13; Nitric oxide

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; MESSENGER RNA; NITRITE;

ADULT; ARTICLE; ASTHMA; BRONCHUS; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; ARGINASE; ASTHMA; BLOTTING, WESTERN; BRONCHI; BRONCHOSCOPY; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 44249117365     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02969.x     Document Type: Article

References (41)

1. Hamid Q, Springall DR, Riveros-Moreno V et al. Induction of nitric oxide synthase in asthma. Lancet 1993 342 : 1510 3.
2. Howarth PH, Redington AE, Springall DR et al. Epithelially derived endothelin and nitric oxide in asthma. Int Arch Allergy Immunol 1995 107 : 228 30.
3. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998 102 : 1200 7.
4. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 352 : 2163 73.
5. Smith AD, Cowan JO, Filsell S et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004 169 : 473 8.
6. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995 92 : 7809 13.
7. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 1992 182 : 1155 9.
8. Bogdan C, Thuring H, Dlaska M, Rollinghoff M, Weiss G. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol 1997 159 : 4506 13.
9. al-Ramadi BK, Meissler JJ Jr., Huang D, Eisenstein TK. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 1992 22 : 2249 54.
10. Donnelly LE, Barnes PJ. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol 2002 26 : 144 51.
11. Guo FH, Uetani K, Haque SJ et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 1997 100 : 829 38.
12. Suresh V, Mih JD, George SC. Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2007 37 : 97 104.
13. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998 336 (Part 1) : 1 17.
14. Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW, Cederbaum S. The human arginases and arginase deficiency. J Inherit Metab Dis 1998 21 (Suppl 1) : 86 100.
15. Grody WW, Dizikes GJ, Cederbaum SD. Human arginase isozymes. Isozymes Curr Top Biol Med Res 1987 13 : 181 214.
16. Vercelli D. Arginase: marker, effector, or candidate gene for asthma? J Clin Invest 2003 111 : 1815 7.
17. Meurs H, Maarsingh H, Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 2003 24 : 450 5.
18. Li H, Romieu I, Sienra-Monge JJ et al. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol 2006 117 : 119 26.
19. Hakonarson H, Bjornsdottir US, Halapi E et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet 2002 71 : 483 91.
20. Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol 2006 117 : 1446 54.
21. Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999 160 : 1001 8.
22. Chu HW, Balzar S, Seedorf GJ et al. Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. Am J Pathol 2004 165 : 1097 106.
23. Wenzel SE, Trudeau JB, Barnes S et al. TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 2002 169 : 4613 9.
24. Gotoh T, Sonoki T, Nagasaki A, Terada K, Takiguchi M, Mori M. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett 1996 395 : 119 22.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982 126 : 131 8.
26. Hartness ME, Brazier SP, Peers C, Bateson AN, Ashford ML, Kemp PJ. Post-transcriptional control of human maxiK potassium channel activity and acute oxygen sensitivity by chronic hypoxia. J Biol Chem 2003 278 : 51422 32.
27. Rolfe FG, Sewell WA. Analysis of human interleukin-5 gene transcription by a novel nuclear run on method based on the polymerase chain reaction. J Immunol Methods 1997 202 : 143 51.
28. Zhou X, Trudeau JB, Schoonover KJ et al. Interleukin-13 augments transforming growth factor-beta1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts. Am J Physiol Cell Physiol 2005 288 : C435 42.
29. Berkman N, Robichaud A, Robbins RA et al. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 1996 89 : 363 7.
30. Kao YJ, Piedra PA, Larsen GL, Colasurdo GN. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med 2001 163 : 532 9.
31. El-Gayar S, Thuring-Nahler H, Pfeilschifter J, Rollinghoff M, Bogdan C. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol 2003 171 : 4561 8.
32. Paludan SR, Ellermann-Eriksen S, Lovmand J, Mogensen SC. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages. Scand J Immunol 1999 49 : 169 76.
33. Saeftel M, Krueger A, Arriens S et al. Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice. Infect Immun 2004 72 : 322 31.
34. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue-specific regulation and induction by cytokines. J Biol Chem 1996 271 : 27184 7.
35. Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 1998 95 : 7625 30.
36. Wenzel S, Wilbraham D, Fuller R, Burmeister Getz E, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. The Lancet 2007 370 : 1422 31.
37. Geller DA, de Vera ME, Russell DA et al. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol 1995 155 : 4890 8.
38. Guo FH, Comhair SA, Zheng S et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 2000 164 : 5970 80.
39. Zimmermann N, King NE, Laporte J et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003 111 : 1863 74.
40. Bergeron C, Boulet LP, Page N et al. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol 2007 119 : 391 7.
41. Yang M, Rangasamy D, Matthaei KI et al. Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 2006 177 : 5595 603.